FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

15241511000001101: Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
53798301000001115 Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
54214101000001119 Calpol Six Plus 250mg/5ml oral suspension (McNeil Products Ltd) 200 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml Is a Paracetamol 250mg/5ml oral suspension 200 ml true Inferred relationship Existential restriction modifier
Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml Has excipient Paraben and/or paraben derivative false Inferred relationship Existential restriction modifier
Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml Legal category Pharmacy medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml Has AMP Calpol Six Plus 250mg/5ml oral suspension (Pfizer Consumer Healthcare) true Inferred relationship Existential restriction modifier
Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml Has specific active ingredient Paracetamol true Inferred relationship Existential restriction modifier
Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Calpol Six Plus 250mg/5ml oral suspension (McNeil Ltd) 200 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start